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Abstract
Multiple health-promoting effects have been attributed to the consumption of Moringa oleifera leaves, as part of
diet without adequate scientiﬁc credence. This study evaluated the effect of M. oleifera-based diets on nickel (Ni) -
induced hepatotoxicity in rats. Male rats assigned into six groups were given oral administration of 20 mg/kg body
weight nickel sulfate in normal saline and either fed normal diet or M. oleifera-based diets for 21 days. All animals
were sacriﬁced under anesthesia 24 hours after the last treatment. Ni exposure elevated the rat plasma activities of
alanine transaminase, aspartate transaminase and alkaline phosphatase signiﬁcantly. Ni exposure also raised the levels
of triglyceride, total cholesterol and low-density lipoprotein cholesterol while depleting the high-density lipoprotein
cholesterol concentration. Further, Ni exposure raised rat plasma malondialdehyde but depleted reduced glutathione
concentrations. The histopathological presentations revealed inﬂammation and cellular degeneration caused by Ni
exposure. We show evidence that M. oleifera-based diets protected against Ni-induced hepatotoxicity by improving
the rat liver function indices, lipid proﬁle as well as restoring cellular architecture and integrity. Study lends credence
to the health-promoting value of M. oleifera as well as underscores its potential to attenuate hepatic injury.
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Introduction
Moringa oleifera (M. oleifera) Lam is a perennial
plant belonging to the Moringaceae family. The M.
oleifera is an edible plant with impressive range of
medicinal uses and high nutritional value[1].M. oleifera
is a promising medicinal plant found in almost every
country and can grow even in harsh conditions[2]. It is
native to tropical Africa but also widely distributed in
India, Ceylon and Madagascar[3]. The medicinal and
nutritional values of M. oleifera have been well
documented[4–5]. In folk medicine, M. oleifera is used
extensively in the treatment of ascites, rheumatism,
heart damage, venomous bites and as a cardiac and
circulatory stimulant[6]. While every part of the plant
has been shown to possess therapeutic properties[7], the
leaves have been used to treat various ailments like
obesity, cancer, liver cirrhosis and kidney damage[4,8].
The leaves of M. oleifera can be eaten raw, cooked or
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air-dried and stored over a long period of time without
losing its therapeutic properties[9]. In term of phyto-
chemistry, the M. oleifera plant has been implicated for
richness in potassium, calcium, phosphorus, iron,
vitamins A and D, essential amino acids, as well as
antioxidants such as β-carotene, vitamin C and
ﬂavonoids[10–12]. Moreover, studies have demonstrated
the relative safety of the plant[13–14].
Perhaps, the numerous medicinal and nutritional
signiﬁcances of M. oleifera[4,8–9,15–16] are fueling the
dietary consumption of M. oleifera for personal health
preservation and/or self-medication. Meanwhile, there is
growing advocacy for the addition of M. oleifera to diet
as an adjunct to therapy for personal health improve-
ment[9,17]. In light of the many health-promoting beneﬁts
attributed to the consumption of M. oleifera, this study
investigated the protective effect of M. oleifera-based
diets on Ni-induced hepatotoxicity in rats.
Materials and methods
Chemicals and reagents
All chemicals and reagents used were of analytical
grade. Commercial reagent kits for the assay of alkaline
phosphatase (ALP), aspartate aminotransferase (AST),
alanine aminotransferases (ALT), total cholesterol (TC),
total protein (TP), triglyceride (TAG), high density
lipoprotein cholesterol (HDL-C) were supplied by
Randox Diagnostics, Crumlin, UK.
Experimental animals
Thirty-six male rats of Wistar strain weighing
between (190-210) g were obtained from the Experi-
mental Animal Farm at the University of Ilorin, Ilorin,
Nigeria. The Wistar rats were placed in plastic animal
cages and housed in a well-ventilated experimental
room. The rats were allowed to acclimatize for a period
of 14 days before the commencement of treatments. The
animals were maintained at (225)°C with humidity
control with automatic dark and light cycle of 12 hours.
The animals were given standard rat feed and clean
drinkable water ad libitum. Handling of animals was in
accordance with relevant local institutional and ethical
guidelines as approved for scientiﬁc study.
M. Oleifera
The leaves of M. Oleifera were harvested at the
Landmark University Farm, Omu-Aran, Nigeria. The
leaves were identiﬁed and authenticated by Mr Bolu
Ajayi at the Herbarium Unit, Department of Plant
Biology, University of Ilorin, Ilorin, Nigeria. The
specimen voucher number is VIH 001/1008. Leaves
were air-dried and ground into powder. The powdered
leave material was stored at room temperature in cool
dry environment until required for use.
Table 1 Formulation of experimental diets
Feed Components Normal Feed (g) 5% Moringa oleifera (g) 10% Moringa oleifera (g) 15% Moringa oleifera (g)
Sucrose 100 100 100 100
Cellulose 40 40 40 40
Soybean 250 250 250 250
Moringa oleifera - 50 100 150
Vitamin Mix 50 50 50 50
D-methionine 4 4 4 4
Corn starch 506 456 406 356
Soybean oil 50 50 50 50
Total 1,000 1,000 1,000 1,000
Table 2 Proximate composition (%) of experimental diets
M. oleifera Ash content Carbohydrate Crude fat Crude ﬁbre Protein Moisture content
0 (control) 5.90.32 43.010.61 6.50.74 11.350.10 25.540.52 8.50.12
5% 6.40.11 30.340.13* 8.250.25 13.030.06 32.880.49* 9.10.31
10% 7.120.03 28.020.05* 10.50.72 12.40.90 32.240.38* 9.720.04
15% 8.50.42 27.220.39* 10.80.30 110.15 31.580.68* 11.50.29
Note: Data are presented as mean valuesstandard error of mean (SEM), n = 3. * vs. control at P< 0.05.
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Preparation of M. oleifera-based diet
M. oleifera-based diets were prepared as previously
described[15]. Brieﬂy, the feed composition consisted of
sucrose, cellulose, soybean, vitamin mix,D-methionine,
corn starch and soybean oil. TheM. oleifera leaves were
added in various concentrations to yield 5%, 10% and
15% supplementation. Additional details are as pre-
sented in Table 1.
Determination of proximate composition
Protein content, crude fat and ﬁber, moisture content,
carbohydrate and ash content of diets were determined
following established protocols as described by the
Association of Ofﬁcial Analytical Chemists[18].
Experimental design
Thirty-six Wistar rats were randomly assigned to
receive NiSO4 and normal rat diet lacking M. oleifera
(Group 1), NiSO4 and 5%M. oleifera-based diet (Group
2), NiSO4 and 10% M. oleifera-based diet (Group 3),
NiSO4 and fed with 15% M. oleifera-based diet (Group
4), normal saline and fed with 15% M. oleifera-based
diet (Group 5) and normal saline and fed with normal rat
diet lacking M. oleifera (Group 6).
The rats were given daily administration of NiSO4 at
20 mg/kg bodyweight by oral gavage. The rats were fed
with either the normal diet or M. oleifera-based diets
daily. Treatments lasted for 21 days. Handling of
animals was consistent with relevant guidelines on the
care and use of laboratory animals[19].
Necroscopy
All animals were fasted overnight and sacriﬁced
under anesthesia in slight diethyl ether, 24 hours after
the last treatments. Blood samples were obtained by
cardiac puncture into clean EDTA bottles. The blood
samples were centrifuged at 4,000 g for 10 minutes in a
refrigerated centrifuge (Anke TDL-5000B, Shanghai,
China) to yield plasma for biochemical determinations.
The liver from each animal was excised into iced
isotonic solution (pH 7.4) and weighed immediately.
The liver samples were then ﬁxed in 10% buffered
neutral formalin and used for histopathologic examina-
tions.
Biochemical assays
The biochemical indices were determined in rat
plasma using a UV/Vis spectrophotometer (Jenway,
Staffordshire, UK) where applicable. The levels of rat
plasma TP, AST (EC: 2.6.1.1), ALT (EC: 2.6.1.2), ALP
(EC: 3.1.3.1), lipid proﬁle including TC, TAG, and
HDL-C were determined using Randox assay kits
(Crumlin, UK). Low-density lipoprotein cholesterol
(LDL-C) was estimated according to the Friedewald
formula[20]. Reduced glutathione level (GSH) was
determined as described by Ellman[21] and Akanji et
al.[22]. Lipid peroxidation was determined by measuring
the formation of thiobarbituric acid reactive substances
(TBARS) using the method described by Niehaus and
Samuelson[23].
Histopathologic examination
The rat liver was ﬁxed in 10% buffered neutral
formalin immediately following excision from animals.
Fixed tissues were subsequently processed for histo-
pathologic examinations as previously described[24].
Capture and scoring for morphological changes were
done by a pathologist blind to the treatments, at the
University of Ilorin Teaching Hospital, Ilorin, Nigeria.
The photomicrographs were captured at100 using the
software Presto Image Folio package.
Data analysis
Data were analyzed using the one-way ANOVA
(GraphPad Software Inc., San Diego, CA, USA) and
presented as the meanstandard error of mean (SEM).
Differences among the group means were determined
by the Tukey's test. Mean values at P< 0.05 were
considered to be signiﬁcant.
Fig. 1 Effect of nickel exposure and Moringa oleifera-based diets. A: Average rat weight; B: rat liver weight; C: liver-to-bodyweight ratio.
Data are presented as mean valuestandard error of mean (SEM), n = 6. Relative to nickel only group (control), *P< 0.05, **P< 0.01 and
***P< 0.001.
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Fig. 2 Effect of nickel exposure andMoringa oleifera-based diets. A: Rat plasma protein concentration B: Rat plasma alanine transaminase
activity. C: Rat plasma aspartate transaminase activity. D: Rat plasma alkaline phosphatase activity. Data are presented as mean valuestandard
error of mean (SEM), n = 6. ***P< 0.001 relative to nickel only group (control).
Fig. 3 Effect of nickel exposure andMoringa oleifera-based diets. A: Rat plasma total cholesterol concentration; B: rat plasma tryglyceride
concentration; C: rat plasma high density lipoprotein-cholesterol (HDL-C) concentration; D: rat plasma low density lipoprotein-cholesterol
(LDL-C) concentration. Data are presented as mean valuestandard error of mean (SEM), ***P< 0.001 relative to nickel only group (control).
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RESULTS
Proximate composition
The experimental diets were evaluated for proximate
composition using the AOAC protocols. The contents
of crude fat, ﬁber, moisture and ash in the normal diet
and M. oleifera-based diets showed no signiﬁcant
difference (Table 2). The carbohydrate content of
M. oleifera supplemented diets decreased with increas-
ing concentration of M. oleifera relative to the normal
diet. Conversely, M. oleifera-based diets had higher
protein content.
Body and liver weights
Ni exposure caused reduction in rat body and liver
weights (Fig. 1). Ni exposure also altered the liver-to-
bodyweight ratio. However, feeding rats with M.
oleifera-based diets appreciably improved the rat
weight indices.
Plasma protein and liver marker enzymes
To evaluate for liver function, some biochemical
indices including ALT, AST, ALP and TP were
determined in rat plasma. The rat plasma protein was
depleted following daily exposure to Ni. However, Ni-
induced reduction in plasma protein was mitigated by
the M. oleifera-based diet (Fig. 2). Ni exposure caused
signiﬁcant elevation of rat plasma ALT, AST and ALP,
but these increases were averted in groups sustained on
M. oleifera-based diets.
Fig. 4 Effect of nickel exposure andMoringa oleifera-based diets.A: Atherogenic index (AI) in rats; B: rat plasma malondialdehyde (MDA)
concentration; C: rat plasma reduced glutathione (GSH) concentration. Data are presented as mean valuestandard error of mean (SEM), n = 6.
***P< 0.001 relative to nickel only group (control).
Fig. 5 Photomicrographs of rat liver following exposure to nickel and sustenance on either a normal diet or Moringa oleifera-based
diets. H&E staining (400). A: Nickel group (1) but sustained on normal diet showing inﬂammation and cellular degeneration. B: Nickel group
(2) but sustained on 5% Moringa oleifera diet indicating cellular restoration. C: Nickel group (3) but sustained on 10% Moringa oleifera diet
shows improvement of cellular architecture. D: Nickel group (4) but sustained on 15% Moringa oleifera diet shows restoration of cellular
architecture. E: Group (5) sustained only on 15%Moringa oleifera diet shows intact cellular architecture. F: Group (6) sustained only on normal
diet shows intact cellular architecture.
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Lipid proﬁle
Ni exposure raised (P< 0.05) the rat TC, TAG and
LDL-C. In contrast, rat plasma HDL-C was depleted
following Ni exposure. The M. oleifera-based diets
reversed Ni-induced lipid proﬁle alterations (Fig. 3).
Atherogenic index (AI), lipid peroxidation and
reduced glutathione
Furthermore, Ni exposure raised the rat AI and
increased the plasma concentration of MDA while
decreasing the concentration of GSH. However, feeding
M. oleifera-based diets to rats lowered the AI, reduced
the level of MDA and raised the GSH concentration
(Fig. 4).
Histopathologic changes
The histopathological presentations revealed inimical
cellular alterations including inﬂammation caused by Ni
exposure. However, feeding M. oleifera-based diets to
rats restored the cellular architecture and integrity
(Fig. 5).
DISCUSSION
This study investigated the protective effect of M.
oleifera-based diets on Ni-induced hepatotoxicity. The
proximate composition of diets revealed high protein
but low carbohydrate content for M. oleifera-based
diets. This is consistent with previous ﬁndings[8,25–27],
and may indicate relevance for nutritional management
of metabolic related disorder.
Earlier studies showed that change to body or organ
weights after chemical exposure may indicate
toxicity[28–29]. In the present study, Ni exposure caused
rat weight loss as well as alterations in vital organ
weights in manners that may suggest ensuing adverse
effect. However, M. oleifera-based diets improved Ni-
induced rat weight loss, thus ameliorating the effect of
Ni-induced toxicity. Further, Ni exposure caused liver
injury evidenced by the elevated plasma activities of
ALT, AST and ALP. Elevated liver function indices
have been shown to implicate cellular damage[30–31].
Conversely, the M. oleifera-based diets demonstrated
protection against Ni assault on rat by improving the
liver function indices. Our ﬁndings are in consonance
with previous reports which demonstrated the relative
safety[13], and hepatoprotective potential of M.
oleifera[14,32–33].
Furthermore, the addition of M. oleifera to diets
protected rats against Ni-induced alteration of lipid
proﬁle by elevating the HDL-C while reducing the AI.
This agrees with previous ﬁndings[5,34–35], which
demonstrated the anti-lipidemic and/or cardiovascular-
promoting effect of M. oleifera. The elevation of HDL-
C by M. oleifera-based diets resulted in the decrease of
atherogenic index (AI) and may indicate thatM. oleifera
has potential for cardiovascular health-promoting effect.
Also, we determined the concentration of GSH and
MDA in rat plasma as early indicators of oxidative
stress. Ni exposure raised the rat plasma MDA but
lowered GSH concentrations. This may indicate the
presence of lipid peroxidation as well as ensuing
oxidative stress caused by Ni exposure. However, the
M. oleifera-based diets elevated plasma GSH concen-
tration while decreasing the MDA concentration in clear
demonstration of protective capacity against Ni-induced
oxidative cellular damage. The ﬁndings support earlier
reports which showed the capability of M. oleifera to
assuage and protect against drug-induced oxidative
stress[1,36–37]. In like manner, separate studies have
demonstrated the potential of M. oleifera to ameliorate
oxidative stress[38–39]. Further, the histopathology
revealed Ni-induced inﬂammatory processes and cel-
lular degeneration. However, these cellular lesions were
conspicuously absent in the groups sustained on
M. oleifera-based diets, thus reinforcing the hepatopro-
tective potential of M. oleifera-based diets. These
ﬁndings are further evidence of the nutritional and
medicinal value of M. oleifera. According to existing
reports, M. oleifera leaves have high polyphenolic
contents among other phyto-constituents which could
be responsible for several of the medicinal potential[1,4].
The protective effect ofM. oleifera on indices of lipid
proﬁle, liver function and oxidative stress may
substantiate its inclusion as part of diet for personal
health improvement. In summary, the addition of
M. oleifera as part of diet holds prospects which may
be explored in several signiﬁcant ways; e.g. for workers
in the mining industries or other related sectors where
the frequency of exposure to heavy metals is high,
consumption of diet containing M. oleifera may help
protect against occupational health risks.
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